Barclays’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.44M | Buy |
140,939
+40,929
| +41% | +$1.29M | ﹤0.01% | 1709 |
|
|
2025
Q1 | $3.28M | Sell |
100,010
-22,839
| -19% | -$748K | ﹤0.01% | 1708 |
|
|
2024
Q4 | $4.44M | Buy |
122,849
+14,061
| +13% | +$508K | ﹤0.01% | 1687 |
|
|
2024
Q3 | $3.39M | Buy |
108,788
+51,005
| +88% | +$1.59M | ﹤0.01% | 1803 |
|
|
2024
Q2 | $1.55M | Sell |
57,783
-22,793
| -28% | -$610K | ﹤0.01% | 1866 |
|
|
2024
Q1 | $2.75M | Sell |
80,576
-22,223
| -22% | -$758K | ﹤0.01% | 1725 |
|
|
2023
Q4 | $2.98M | Buy |
102,799
+47,955
| +87% | +$1.39M | ﹤0.01% | 1873 |
|
|
2023
Q3 | $1.51M | Buy |
54,844
+1,021
| +2% | +$28.1K | ﹤0.01% | 1828 |
|
|
2023
Q2 | $1.62M | Buy |
53,823
+8,585
| +19% | +$258K | ﹤0.01% | 1873 |
|
|
2023
Q1 | $1.64M | Buy |
45,238
+636
| +1% | +$23.1K | ﹤0.01% | 1767 |
|
|
2022
Q4 | $1.59M | Sell |
44,602
-6,337
| -12% | -$226K | ﹤0.01% | 1778 |
|
|
2022
Q3 | $1.72M | Buy |
50,939
+1,449
| +3% | +$49K | ﹤0.01% | 1758 |
|
|
2022
Q2 | $1.43M | Sell |
49,490
-17,556
| -26% | -$508K | ﹤0.01% | 1804 |
|
|
2022
Q1 | $2.17M | Sell |
67,046
-10,552
| -14% | -$341K | ﹤0.01% | 1715 |
|
|
2021
Q4 | $2.26M | Buy |
77,598
+15,098
| +24% | +$440K | ﹤0.01% | 1746 |
|
|
2021
Q3 | $1.67M | Buy |
62,500
+28,132
| +82% | +$750K | ﹤0.01% | 1977 |
|
|
2021
Q2 | $1.06M | Sell |
34,368
-72,390
| -68% | -$2.23M | ﹤0.01% | 2086 |
|
|
2021
Q1 | $2.8M | Sell |
106,758
-13,929
| -12% | -$365K | ﹤0.01% | 1624 |
|
|
2020
Q4 | $3.04M | Sell |
120,687
-34,941
| -22% | -$879K | ﹤0.01% | 1322 |
|
|
2020
Q3 | $3.24M | Buy |
155,628
+15,535
| +11% | +$324K | ﹤0.01% | 1202 |
|
|
2020
Q2 | $3.33M | Buy |
140,093
+46,651
| +50% | +$1.11M | ﹤0.01% | 1150 |
|
|
2020
Q1 | $1.68M | Buy |
93,442
+5,507
| +6% | +$99.1K | ﹤0.01% | 1421 |
|
|
2019
Q4 | $2.09M | Buy |
87,935
+26,507
| +43% | +$629K | ﹤0.01% | 1854 |
|
|
2019
Q3 | $1.69M | Sell |
61,428
-1,701
| -3% | -$46.7K | ﹤0.01% | 1894 |
|
|
2019
Q2 | $2.09M | Sell |
63,129
-18,393
| -23% | -$609K | ﹤0.01% | 1773 |
|
|
2019
Q1 | $2.86M | Buy |
81,522
+12,540
| +18% | +$439K | ﹤0.01% | 1310 |
|
|
2018
Q4 | $2.29M | Sell |
68,982
-11,961
| -15% | -$397K | ﹤0.01% | 1279 |
|
|
2018
Q3 | $4.08M | Buy |
80,943
+56,081
| +226% | +$2.82M | ﹤0.01% | 1195 |
|
|
2018
Q2 | $1.49M | Buy |
24,862
+543
| +2% | +$32.5K | ﹤0.01% | 1595 |
|
|
2018
Q1 | $1.11M | Buy |
24,319
+13,047
| +116% | +$597K | ﹤0.01% | 1723 |
|
|
2017
Q4 | $450K | Buy |
11,272
+7,964
| +241% | +$318K | ﹤0.01% | 2170 |
|
|
2017
Q3 | $133K | Sell |
3,308
-3,547
| -52% | -$143K | ﹤0.01% | 2582 |
|
|
2017
Q2 | $296K | Sell |
6,855
-1,054
| -13% | -$45.5K | ﹤0.01% | 2216 |
|
|
2017
Q1 | $247K | Buy |
7,909
+5,685
| +256% | +$178K | ﹤0.01% | 2366 |
|
|
2016
Q4 | $56K | Sell |
2,224
-18,063
| -89% | -$455K | ﹤0.01% | 2796 |
|
|
2016
Q3 | $501K | Sell |
20,287
-96
| -0.5% | -$2.37K | ﹤0.01% | 1731 |
|
|
2016
Q2 | $415K | Sell |
20,383
-1,966
| -9% | -$40K | ﹤0.01% | 1837 |
|
|
2016
Q1 | $335K | Sell |
22,349
-10,070
| -31% | -$151K | ﹤0.01% | 1885 |
|
|
2015
Q4 | $422K | Sell |
32,419
-75,905
| -70% | -$988K | ﹤0.01% | 1751 |
|
|
2015
Q3 | $1.52M | Buy |
108,324
+107,021
| +8,213% | +$1.5M | ﹤0.01% | 1225 |
|
|
2015
Q2 | $22K | Sell |
1,303
-13,341
| -91% | -$225K | ﹤0.01% | 2936 |
|
|
2015
Q1 | $175K | Buy |
14,644
+9,676
| +195% | +$116K | ﹤0.01% | 2313 |
|
|
2014
Q4 | $40K | Sell |
4,968
-11,894
| -71% | -$95.8K | ﹤0.01% | 3128 |
|
|
2014
Q3 | $135K | Buy |
16,862
+6,651
| +65% | +$53.2K | ﹤0.01% | 2500 |
|
|
2014
Q2 | $102K | Sell |
10,211
-17,837
| -64% | -$178K | ﹤0.01% | 2712 |
|
|
2014
Q1 | $225K | Buy |
28,048
+14,013
| +100% | +$112K | ﹤0.01% | 2323 |
|
|
2013
Q4 | $98K | Sell |
14,035
-4,381
| -24% | -$30.6K | ﹤0.01% | 3045 |
|
|
2013
Q3 | $129K | Buy |
18,416
+14,850
| +416% | +$104K | ﹤0.01% | 2823 |
|
|
2013
Q2 | $23K | Buy |
+3,566
| New | +$23K | ﹤0.01% | 3640 |
|